Life cycle management of analytical methods

Graphical abstract Figure. No Caption available. HighlightsLife cycle management as novel strategy for analytical methods.Quality‐by‐design principles for analytical methods.Integrated method development and performance characterization approach.Proposal of new guidelines for regulated environment in progress. ABSTRACT In modern process management, the life cycle concept gains more and more importance. It focusses on the total costs of the process from invest to operation and finally retirement. Also for analytical procedures an increasing interest for this concept exists in the recent years. The life cycle of an analytical method consists of design, development, validation (including instrumental qualification, continuous method performance verification and method transfer) and finally retirement of the method. It appears, that also regulatory bodies have increased their awareness on life cycle management for analytical methods. Thus, the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH), as well as the United States Pharmacopeial Forum discuss the enrollment of new guidelines that include life cycle management of analytical methods. The US Pharmacopeia (USP) Validation and Verification expert panel already proposed a new General Chapter ⟨1220⟩ “The Analytical Procedure Lifecycle” for integration into USP. Furthermore, also in the non‐regulated environment a growing interest on life cycle management is seen. Quality‐by‐design based method development results in increased method robustness. Thereby a decreased effort is needed for method performance verification, and post‐approval changes as well as minimized risk of method related out‐of‐specification results. This strongly contributes to reduced costs of the method during its life cycle.

[1]  Evelien Wynendaele,et al.  Surface acoustic wave biosensor as a functional-quality method in pharmaceutics , 2015 .

[2]  Yvan Vander Heyden,et al.  Prediction of peptide retention at different HPLC conditions from multiple linear regression models. , 2005, Journal of proteome research.

[3]  Ramalingam Peraman,et al.  Analytical Quality by Design: A Tool for Regulatory Flexibility and Robust Analytics , 2015, International journal of analytical chemistry.

[4]  P. Haddad,et al.  Prediction of retention in hydrophilic interaction liquid chromatography using solute molecular descriptors based on chemical structures. , 2017, Journal of chromatography. A.

[5]  Karl Fraser,et al.  Predicting retention time in hydrophilic interaction liquid chromatography mass spectrometry and its use for peak annotation in metabolomics , 2014, Metabolomics.

[6]  Jane Weitzel,et al.  Establishment of Measurement Requirements – Analytical Target Profile and Decision Rules , 2014 .

[7]  X. Yang,et al.  Quality by design (QbD) based development of a stability indicating HPLC method for drug and impurities. , 2011, Journal of chromatographic science.

[8]  K. Unger,et al.  Reverse-phase ion-pair chromatography of polyvalent ions using oligonucleotides as model substances. , 1982, Analytical biochemistry.

[9]  T. Schofield,et al.  Application of an innovative design space optimization strategy to the development of liquid chromatographic methods to combat potentially counterfeit nonsteroidal anti-inflammatory drugs. , 2012, Journal of chromatography. A.

[10]  Christopher Singleton,et al.  Recent advances in bioanalytical sample preparation for LC-MS analysis. , 2012, Bioanalysis.

[11]  Abdelmjid Abourriche,et al.  Statistical tools and approaches to validate analytical methods: methodology and practical examples , 2017 .

[12]  Ana Stajić,et al.  Quality by Design in the development of hydrophilic interaction liquid chromatography method with gradient elution for the analysis of olanzapine , 2017, Journal of pharmaceutical and biomedical analysis.

[13]  I. Krull,et al.  A Quality-by-Design Methodology for Rapid LC Method Development, Part III , 2008 .

[14]  Tong-Yuan Yang,et al.  Characterization of critical reagents in ligand-binding assays: enabling robust bioanalytical methods and lifecycle management. , 2013, Bioanalysis.

[15]  René P Schwarzenbach,et al.  Identification of transformation products of organic contaminants in natural waters by computer-aided prediction and high-resolution mass spectrometry. , 2009, Environmental science & technology.

[16]  H. Wätzig,et al.  Application of the equivalence test according to a concept for analytical method transfers from the International Society for Pharmaceutical Engineering (ISPE). , 2005, Journal of pharmaceutical and biomedical analysis.

[17]  Joachim Ermer,et al.  Method Validation in Pharmaceutical Analysis : A Guide to Best Practice , 2014 .

[18]  R. Marini,et al.  Application of an innovative design space optimization strategy to the development of LC methods for the simultaneous screening of antibiotics to combat poor quality medicines. , 2013, Journal of pharmaceutical and biomedical analysis.

[19]  J Ermer,et al.  Validation in pharmaceutical analysis. Part I: an integrated approach. , 2001, Journal of pharmaceutical and biomedical analysis.

[20]  M. Jovanović,et al.  Quality by Design approach in the development of hydrophilic interaction liquid chromatographic method for the analysis of iohexol and its impurities. , 2015, Journal of pharmaceutical and biomedical analysis.

[21]  C. Mant,et al.  Prediction of peptide retention times in reversed-phase high-performance liquid chromatography II. Correlation of observed and predicted peptide retention times factors and influencing the retention times of peptides , 1986 .

[22]  I. Molnár,et al.  Aspects of the "Design Space" in high pressure liquid chromatography method development. , 2010, Journal of chromatography. A.

[23]  Steven M Cramer,et al.  Investigation of protein binding affinity and preferred orientations in ion exchange systems using a homologous protein library , 2009, Biotechnology and bioengineering.

[24]  M. W. Dong,et al.  Handbook Of Pharmaceutical Analysis By Hplc , 2008 .

[25]  U. Urleb,et al.  Quality by design based optimization of a high performance liquid chromatography method for assay determination of low concentration preservatives in complex nasal formulations. , 2015, Acta chimica Slovenica.

[26]  J. Veuthey,et al.  Computer assisted liquid chromatographic method development for the separation of therapeutic proteins. , 2016, The Analyst.

[27]  P. Haddad,et al.  Performance comparison of partial least squares-related variable selection methods for quantitative structure retention relationships modelling of retention times in reversed-phase liquid chromatography. , 2015, Journal of chromatography. A.

[28]  J. Ermer,et al.  The transfer of analytical procedures. , 2013, Journal of pharmaceutical and biomedical analysis.

[29]  T. Madrakian,et al.  Nanomaterials as sorbents for sample preparation in bioanalysis: A review. , 2017, Analytica chimica acta.

[30]  Douglas Both,et al.  Analytical Method Quality by Design for an On-Line Near-Infrared Method to Monitor Blend Potency and Uniformity , 2014, Journal of Pharmaceutical Innovation.

[31]  S. Hansen,et al.  Bioanalysis of pharmaceuticals : sample preparation, separation techniques, and mass spectrometry , 2015 .

[32]  P. Kulhánek,et al.  Sequence-dependent separation of trinucleotides by ion-interaction reversed-phase liquid chromatography-A structure-retention study assisted by soft-modelling and molecular dynamics. , 2016, Journal of chromatography. A.

[33]  N. Etxebarria,et al.  Improvement of the chromatographic separation of several 1,4-dihydropyridines calcium channel antagonist drugs by experimental design. , 2005, Journal of chromatographic science.

[34]  Emma L. Schymanski,et al.  Identifying small molecules via high resolution mass spectrometry: communicating confidence. , 2014, Environmental science & technology.

[35]  E. Wynendaele,et al.  An analytical quality by design (aQbD) approach for a L-asparaginase activity method. , 2016, Journal of pharmaceutical and biomedical analysis.

[36]  J. Loco,et al.  Calculation of the decision limit (CCalpha) and the detection capability (CCbeta) for banned substances: the imperfect marriage between the quantitative and the qualitative criteria. , 2007, Analytica chimica acta.

[37]  Alexander H Schmidt Development of an HPLC Method for the Determination of Hydroxycinnamic Acid Derivatives in Cimicifuga racemosa (Black Cohosh) Extracts Using an Automated Method Development System , 2005 .

[38]  B. Nickerson Sample Preparation of Pharmaceutical Dosage Forms , 2011 .

[39]  L. Snyder,et al.  Selectivity differences for C18 and C8 reversed-phase columns as a function of temperature and gradient steepness. I. Optimizing selectivity and resolution. , 2000, Journal of chromatography. A.

[40]  L. T. Taylor,et al.  The use of supercritical fluid extraction for sample preparation of pharmaceutical formulations. , 1997, Journal of pharmaceutical and biomedical analysis.

[41]  Andrea Armirotti,et al.  Kernel-Based, Partial Least Squares Quantitative Structure-Retention Relationship Model for UPLC Retention Time Prediction: A Useful Tool for Metabolite Identification. , 2016, Analytical chemistry.

[42]  Milton L. Lee,et al.  Sub-2 μm porous and nonporous particles for fast separation in reversed-phase high performance liquid chromatography , 2006 .

[43]  Imre Molnar,et al.  Computerized design of separation strategies by reversed-phase liquid chromatography: development of DryLab software. , 2002, Journal of chromatography. A.

[44]  Siegfried Wartewig,et al.  Pharmaceutical applications of Mid-IR and Raman spectroscopy. , 2005, Advanced drug delivery reviews.

[45]  G. Murkitt,et al.  Sample preparation for the HPLC analysis of drugs in biological fluids. , 1989, Journal of pharmaceutical and biomedical analysis.

[46]  A. Alexander,et al.  A stepwise strategy employing automated screening and DryLab modeling for the development of robust methods for challenging high performance liquid chromatography separations: a case study. , 2011, Analytica chimica acta.

[47]  Janusz Pawliszyn,et al.  Quantitative structure-retention relationships models for prediction of high performance liquid chromatography retention time of small molecules: endogenous metabolites and banned compounds. , 2013, Analytica chimica acta.

[48]  Alexander H. Schmidt,et al.  Computer-assisted optimization in the development of a high-performance liquid chromatographic method for the analysis of kava pyrones in Piper methysticum preparations. , 2002, Journal of chromatography. A.

[49]  Bhupinder Singh,et al.  Systematic Development and Validation of a Thin-Layer Densitometric Bioanalytical Method for Estimation of Mangiferin Employing Analytical Quality by Design (AQbD) Approach. , 2016, Journal of chromatographic science.

[50]  Simon J. Bale,et al.  Quality by Design for Analytical Methods , 2010 .

[51]  Ian D Wilson,et al.  An overview of fecal sample preparation for global metabolic profiling. , 2015, Journal of pharmaceutical and biomedical analysis.

[52]  Joachim Ermer,et al.  Validation in pharmaceutical analysis. Part II: Central importance of precision to establish acceptance criteria and for verifying and improving the quality of analytical data. , 2005, Journal of pharmaceutical and biomedical analysis.

[53]  STIMULI TO THE REVISION PROCESS , 2017 .

[54]  C. López-Morales,et al.  Design of a strong cation exchange methodology for the evaluation of charge heterogeneity in glatiramer acetate , 2017, Journal of pharmaceutical and biomedical analysis.

[55]  Peter W Carr,et al.  The Hydrophobic-Subtraction Model of Reversed-Phase Column Selectivity. , 2012, Advances in chromatography.

[56]  David G. Holcombe,et al.  A life cycle approach to method management , 2001 .

[57]  M. Swartz Ultra performance liquid chromatography (UPLC) : An introduction , 2005 .

[58]  Lubertus Bijlsma,et al.  Critical evaluation of a simple retention time predictor based on LogKow as a complementary tool in the identification of emerging contaminants in water. , 2015, Talanta.

[59]  Ich Harmonised,et al.  INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE , 2006 .

[60]  L. Snyder,et al.  The Linear-Solvent-Strength Model of Gradient Elution , 1998 .

[61]  Jelena Terzić,et al.  Application of Analytical Quality by Design concept for bilastine and its degradation impurities determination by hydrophilic interaction liquid chromatographic method. , 2016, Journal of pharmaceutical and biomedical analysis.

[62]  R. Plumb,et al.  Comprehensive investigation of the influence of acidic, basic, and organic mobile phase compositions on bioanalytical assay sensitivity in positive ESI mode LC/MS/MS. , 2012, Journal of pharmaceutical and biomedical analysis.

[63]  M. Swartz,et al.  New frontiers in chromatography , 2005 .

[64]  R. Marini,et al.  Combination of partial least squares regression and design of experiments to model the retention of pharmaceutical compounds in supercritical fluid chromatography. , 2017, Journal of chromatography. A.

[65]  Thomas Letzel,et al.  Non-target screening with high-resolution mass spectrometry: critical review using a collaborative trial on water analysis , 2015, Analytical and Bioanalytical Chemistry.

[66]  H. C. Bertram,et al.  Time-saving design of experiment protocol for optimization of LC-MS data processing in metabolomic approaches. , 2013, Analytical chemistry.

[67]  M. Ibáñez,et al.  UHPLC-QTOF MS screening of pharmaceuticals and their metabolites in treated wastewater samples from Athens. , 2017, Journal of hazardous materials.

[68]  A. Pelander,et al.  Prediction of liquid chromatographic retention for differentiation of structural isomers. , 2012, Analytica chimica acta.

[69]  V. Samanidou,et al.  Green approaches in sample preparation of bioanalytical samples prior to chromatographic analysis. , 2017, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[70]  R. Bro,et al.  Near-infrared chemical imaging (NIR-CI) on pharmaceutical solid dosage forms-comparing common calibration approaches. , 2008, Journal of pharmaceutical and biomedical analysis.

[71]  Leon P Barron,et al.  Prediction of chromatographic retention time in high-resolution anti-doping screening data using artificial neural networks. , 2013, Analytical chemistry.

[72]  X. Yang,et al.  Quality by design (QbD) based development and validation of an HPLC method for amiodarone hydrochloride and its impurities in the drug substance. , 2014, Journal of pharmaceutical and biomedical analysis.

[73]  Joachim Ermer,et al.  Analytical Validation within the Pharmaceutical Lifecycle , 2014 .

[74]  Y. Heyden,et al.  Support Vector Regression Based QSPR for the Prediction of Retention Time of Peptides in Reversed-Phase Liquid Chromatography , 2014, Chromatographia.

[75]  S Furlanetto,et al.  An integrated quality by design and mixture-process variable approach in the development of a capillary electrophoresis method for the analysis of almotriptan and its impurities. , 2014, Journal of chromatography. A.

[76]  G. L. Reid,et al.  REVERSED-PHASE LIQUID CHROMATOGRAPHIC METHOD DEVELOPMENT IN AN ANALYTICAL QUALITY BY DESIGN FRAMEWORK , 2013 .

[77]  Lloyd R. Snyder,et al.  Practical HPLC method development , 1988 .

[78]  J. R. Torres-Lapasió,et al.  Models and objective functions for the optimisation of selectivity in reversed-phase liquid chromatography. , 2006, Analytica chimica acta.

[79]  P. Haddad,et al.  Towards a chromatographic similarity index to establish localized quantitative structure-retention models for retention prediction: Use of retention factor ratio. , 2017, Journal of chromatography. A.

[80]  Melissa D'Archangelo Flow cytometry: New guidelines to support its clinical application , 2007, Cytometry. Part B, Clinical cytometry.

[81]  Edward Tabler,et al.  Validation and life-cycle management of a quantitative ligand-binding assay for the measurement of Nulojix(®), a CTLA-4-Fc fusion protein, in renal and liver transplant patients. , 2012, Bioanalysis.

[82]  Cyrus Agarabi,et al.  Application of quality by design elements for the development and optimization of an analytical method for protamine sulfate. , 2012, Journal of pharmaceutical and biomedical analysis.

[83]  S. L Kiprotich An insight on international conference of harmonisation of technical requirements for registration of pharmaceutical products for human use (ICH). , 2009 .

[84]  C. Frömke,et al.  Analytical method transfer: improving interpretability with ratio-based statistical approaches. , 2013, Journal of pharmaceutical and biomedical analysis.

[85]  H. Wätzig,et al.  Application of the equivalence test for analytical method transfers: testing precision using the United States Pharmacopoeia concept (1010). , 2006, Journal of pharmaceutical and biomedical analysis.

[86]  Michael E. Swartz,et al.  UPLC TM : An Introduction and Review , 2005 .

[87]  Evsevios Hadjicostas,et al.  Validation of Analytical Methods – to be Fit for the Purpose , 2010 .

[88]  C. Breneman,et al.  Prediction of protein retention in ion-exchange systems using molecular descriptors obtained from crystal structure. , 2001, Analytical chemistry.

[89]  Enrique Carredano,et al.  Electrostatic calculations and quantitative protein retention models for ion exchange chromatography. , 2006, Journal of chromatography. A.

[90]  Sam H Haidar,et al.  2016 White Paper on recent issues in bioanalysis: focus on biomarker assay validation (BAV): (Part 3 - LBA, biomarkers and immunogenicity). , 2016, Bioanalysis.

[91]  Slobodan ai,et al.  Pharmaceutical Applications of Raman Spectroscopy , 2007 .

[92]  J. Veuthey,et al.  Fast analysis in liquid chromatography using small particle size and high pressure. , 2006, Journal of separation science.

[93]  Michael E. Swartz,et al.  UPLC™: An Introduction and Review , 2005 .

[94]  Sophie Vaslin-Reimann,et al.  Estimating sampling and analysis uncertainties to assess the fitness for purpose of a water quality monitoring network , 2016, Accreditation and Quality Assurance.

[95]  Bertil Magnusson,et al.  The Fitness for Purpose of Analytical Methods , 2014 .

[96]  Michael Thompson,et al.  Harmonized guidelines for single-laboratory validation of methods of analysis (IUPAC Technical Report) , 2002 .

[97]  Lubertus Bijlsma,et al.  Suspect screening of large numbers of emerging contaminants in environmental waters using artificial neural networks for chromatographic retention time prediction and high resolution mass spectrometry data analysis. , 2015, The Science of the total environment.

[98]  O. Svensson,et al.  A quality control method enhancement concept-Continual improvement of regulatory approved QC methods. , 2016, Journal of pharmaceutical and biomedical analysis.

[100]  Alessandro Morais Saviano,et al.  Measurement uncertainty in pharmaceutical analysis and its application , 2013, Journal of pharmaceutical analysis.

[101]  Michael W. Dong,et al.  Modern HPLC for Practicing Scientists , 2006 .

[102]  T. Hanai,et al.  Optimization of retention time of aromatic acids in liquid chromatography from log P and predicted pKa values , 1984 .

[103]  K. Gaudin,et al.  Using an innovative combination of quality-by-design and green analytical chemistry approaches for the development of a stability indicating UHPLC method in pharmaceutical products. , 2015, Journal of pharmaceutical and biomedical analysis.

[104]  Benjamin Debrus,et al.  New methodology for the development of chromatographic methods with bioanalytical application. , 2011, Bioanalysis.

[105]  Philippe Hubert,et al.  Screening study of SFC critical method parameters for the determination of pharmaceutical compounds. , 2016, Journal of pharmaceutical and biomedical analysis.

[106]  Gillian L McEneff,et al.  Gradient liquid chromatographic retention time prediction for suspect screening applications: A critical assessment of a generalised artificial neural network-based approach across 10 multi-residue reversed-phase analytical methods. , 2016, Talanta.

[107]  R. Plackett,et al.  THE DESIGN OF OPTIMUM MULTIFACTORIAL EXPERIMENTS , 1946 .

[108]  Olaf H Drummer,et al.  Validation of new methods. , 2007, Forensic science international.

[109]  Pierre Lebrun,et al.  Application of design space optimization strategy to the development of LC methods for simultaneous analysis of 18 antiretroviral medicines and 4 major excipients used in various pharmaceutical formulations , 2017, Journal of pharmaceutical and biomedical analysis.

[110]  Alban Arrault,et al.  UPLC–MS retention time prediction: a machine learning approach to metabolite identification in untargeted profiling , 2015, Metabolomics.

[111]  Darko Ivanović,et al.  Comparison of Full Factorial Design, Central Composite Design, and Box-Behnken Design in Chromatographic Method Development for the Determination of Fluconazole and Its Impurities , 2014 .

[112]  A. Squirrell,et al.  Eurachem/CITAC Guide - Use of Uncertainty Information in Compliance Assessment, 1st edn. , 2015 .

[113]  M. Jovanović,et al.  THEORETICAL AND EMPIRICAL MODELS IN HYDROPHILIC INTERACTION LIQUID CHROMATOGRAPHY , 2014 .

[114]  J. Dolan,et al.  Selectivity differences for C18 and C8 reversed-phase columns as a function of temperature and gradient steepness. II. Minimizing column reproducibility problems. , 2000, Journal of chromatography. A.

[115]  R. Marini,et al.  Optimization and validation of a fast supercritical fluid chromatography method for the quantitative determination of vitamin D3 and its related impurities. , 2017, Journal of chromatography. A.

[116]  Joseph Moses Juran Juran on Quality by Design: The New Steps for Planning Quality into Goods and Services , 1992 .

[117]  Valeri I. Babushok,et al.  Retention Characteristics of Peptides in RP-LC: Peptide Retention Prediction , 2010 .

[118]  I. Molnár,et al.  Using an innovative Quality-by-Design approach for development of a stability indicating UHPLC method for ebastine in the API and pharmaceutical formulations. , 2013, Journal of pharmaceutical and biomedical analysis.

[119]  Andreas Zell,et al.  Preanalytical aspects and sample quality assessment in metabolomics studies of human blood. , 2013, Clinical chemistry.

[120]  I. Apostol,et al.  Comparison of different approaches for evaluation of the detection and quantitation limits of a purity method: a case study using a capillary isoelectrofocusing method for a monoclonal antibody. , 2009, Analytical biochemistry.

[121]  M. Swartz 6 Contemporary liquid chromatographic systems for method development , 2007 .

[122]  Ana Vemić,et al.  Development of liquid chromatographic method for the analysis of dabigatran etexilate mesilate and its ten impurities supported by quality-by-design methodology. , 2015, Journal of pharmaceutical and biomedical analysis.

[123]  Roman Szucs,et al.  Evaluation of ultra performance liquid chromatography. Part I. Possibilities and limitations. , 2006, Journal of chromatography. A.

[124]  L. Snyder,et al.  Computer-assisted method development for high performance liquid chromatography: Elsevier, Amsterdam, 1990 (ISBN 0-444-88748-2). xxiv + 682 pp. Price Dfl. 175.00/US $ 79.75 , 1991 .

[125]  A. Oberg,et al.  Optimizing Mass Spectrometry Analyses: A Tailored Review on the Utility of Design of Experiments , 2016, Journal of The American Society for Mass Spectrometry.

[126]  Tsuyoshi Murata,et al.  {m , 1934, ACML.

[127]  G. L. Reid,et al.  No Sample Preparation , 2011 .

[128]  Yimin Hua,et al.  A platform analytical quality by design (AQbD) approach for multiple UHPLC-UV and UHPLC-MS methods development for protein analysis. , 2016, Journal of pharmaceutical and biomedical analysis.

[129]  Davy Guillarme,et al.  Newer Developments in HPLC Impacting Pharmaceutical Analysis : A Brief Review , 2013 .

[130]  P. Haddad,et al.  Towards a chromatographic similarity index to establish localised quantitative structure-retention relationships for retention prediction. II Use of Tanimoto similarity index in ion chromatography. , 2017, Journal of chromatography. A.

[132]  Reza Aalizadeh,et al.  Quantitative Structure-Retention Relationship Models To Support Nontarget High-Resolution Mass Spectrometric Screening of Emerging Contaminants in Environmental Samples , 2016, J. Chem. Inf. Model..

[133]  Gongke Li,et al.  Magnetic separation techniques in sample preparation for biological analysis: a review. , 2014, Journal of pharmaceutical and biomedical analysis.

[134]  P. Hubert,et al.  Improvement of a stability-indicating method by Quality-by-Design versus Quality-by-Testing: a case of a learning process. , 2014, Journal of pharmaceutical and biomedical analysis.

[135]  S. Rudaz,et al.  Improved quality-by-design compliant methodology for method development in reversed-phase liquid chromatography. , 2013, Journal of pharmaceutical and biomedical analysis.

[136]  R. Breitling,et al.  Toward global metabolomics analysis with hydrophilic interaction liquid chromatography-mass spectrometry: improved metabolite identification by retention time prediction. , 2011, Analytical chemistry.

[137]  G. Somsen,et al.  One single, fast and robust capillary electrophoresis method for the direct quantification of intact adenovirus particles in upstream and downstream processing samples. , 2017, Talanta.

[139]  C. West,et al.  Deconvoluting the effects of buffer salt concentration in hydrophilic interaction chromatography on a zwitterionic stationary phase. , 2016, Journal of chromatography. A.

[140]  Y. B. Chavan LIFE CYCLE ASSESSMENT (LCA) APPROACH TO ANALYTICAL METHOD DEVELOPMENT: A REVIEW , 2015 .

[141]  Ming Yan,et al.  Validation of cell‐based fluorescence assays: Practice guidelines from the ICSH and ICCS – part V – assay performance criteria , 2013, Cytometry. Part B, Clinical cytometry.

[142]  Hermann Wätzig,et al.  Efficient and economic HPLC performance qualification. , 2010, Journal of pharmaceutical and biomedical analysis.

[143]  Muriel Noetzli,et al.  Simultaneous determination of antidementia drugs in human plasma: procedure transfer from HPLC-MS to UPLC-MS/MS. , 2012, Journal of pharmaceutical and biomedical analysis.

[144]  S. Furlanetto,et al.  Quality by design in the chiral separation strategy for the determination of enantiomeric impurities: development of a capillary electrophoresis method based on dual cyclodextrin systems for the analysis of levosulpiride. , 2015, Journal of chromatography. A.

[145]  E. Chan,et al.  Applications of monolithic materials for sample preparation. , 2014, Journal of pharmaceutical and biomedical analysis.

[146]  I. Molnár,et al.  Quality by Design: Multidimensional exploration of the design space in high performance liquid chromatography method development for better robustness before validation. , 2012, Journal of chromatography. A.

[147]  Flavia Ruggieri,et al.  Full validation and accreditation of a method to support human biomonitoring studies for trace and ultra-trace elements , 2016 .

[148]  S. A. White,et al.  Evaluation of ultra-performance liquid chromatography in the bioanalysis of small molecule drug candidates in plasma. , 2007, Journal of chromatographic science.

[149]  Joachim Ermer,et al.  Transfer of Analytical Procedures , 2005 .

[150]  Roman Kaliszan,et al.  Predictions of peptides' retention times in reversed‐phase liquid chromatography as a new supportive tool to improve protein identification in proteomics , 2009, Proteomics.

[151]  Bernard A Olsen,et al.  A quality by design approach to impurity method development for atomoxetine hydrochloride (LY139603). , 2008, Journal of pharmaceutical and biomedical analysis.

[152]  R. L. Baglow The reliability parameter and its importance for life cycle management , 1975 .

[153]  Serge Rudaz,et al.  Prediction of retention time in reversed-phase liquid chromatography as a tool for steroid identification. , 2016, Analytica chimica acta.

[154]  I. Molnár,et al.  From Csaba Horváth to Quality by Design: Visualizing Design Space in Selectivity Exploration of HPLC Separations , 2011 .

[155]  Thorsten Verch,et al.  Quality by design for a vaccine release immunoassay: a case study. , 2013, Bioanalysis.

[156]  Wojciech Szpankowski,et al.  Uncertainty Estimates of Purity Measurements Based on Current Information: Toward a “Live Validation” of Purity Methods , 2012, Pharmaceutical Research.

[157]  J. Mazzeo,et al.  A new separation technique takes advantage of suh-2-μm porous particles , 2005 .

[158]  G. L. Reid,et al.  Quantitative Structure Retention Relationship Models in an Analytical Quality by Design Framework: Simultaneously Accounting for Compound Properties, Mobile-Phase Conditions, and Stationary-Phase Properties , 2013 .

[159]  H. Verelst,et al.  Future of high pressure liquid chromatography: do we need porosity or do we need pressure? , 2006, Journal of chromatography. A.

[160]  L A Larew,et al.  Statistical approaches to determine analytical variability and specifications: application of experimental design and variance component analysis. , 1998, Journal of pharmaceutical and biomedical analysis.